News

RHEACELL announced today that it has entered into an exclusive partnership agreement with the AOP Health Group, who will ...
RHEACELL and AOP Health: Strategic partnership to deliver breakthrough therapies for the "butterfly children’s disease" and ...
The FDA urges health care professionals and consumers to report any adverse events related to treatments with Liveyon products, Genetech products or other stem cell treatments to its MedWatch ...
[The FDA is] likely to be subjected to enormous political pressure during Trump 2.0 to weaken oversight of cell and regenerative products. — Paul S. Knoepfler, UC Davis One is the Supreme Court.
DUBLIN, Ohio, May 7, 2025 /PRNewswire/ -- Today, Cardinal Health (NYSE: CAH) released its 2025 Advanced Therapies Report: Revolutionizing patient care – the promise and potential of cell and ...